Member Info for mol42

That would be the 5m loan note announced on 25 Jan 2024 only for this on 28 Feb 24 - what's that under 5 weeks

To date, the Company has drawn a total of £1,600,000 under the Facility. The Board of SkinBioTherapeutics has today provided formal notice to CLG Capital LLC (CLG) (and by proxy Macquarie) that it will not utilise the reminder of the £5m Facility. The Board is in negotiations with the noteholders to discuss timing and rate of conversion and subsequent selling of stock.

Stuart Ashman, CEO of SkinBioTherapeutics said: "We met the CLG team today and have come to an amicable agreement around the Facility and next steps. We believe this is the right decision for the Company. In the meantime, we are very busy integrating the recently acquired Dermatonics, the accelerated Modi/Dermatonics product launch in the Asia, Middle East and Africa regions, and completing the participant study for the acne programme which has generated very positive interim results. We anticipate further updates in the coming weeks in the lead up to the HY results in March."

whilst as Bazza notes on 22nd March the cln was the best option.........

jees if any further evidence was ever needed

the cln note is not the only thing that overhangs this company

mol

On sale from 23 Feb 2024

https://www.amazon.co.uk/MuscleTech-NitroTech-Weightloss-Servings-Chocolate/dp/B0CW9Y256T/ref=sr_1_8?dib=eyJ2IjoiMSJ9.j2lnQLFdow5hZMjAS0VapCW7FprAvMaME9nY1JiRN4HvrT781gvZsEgS7M6k8dmtsO-TxY7Y589UwAM7D80WZnQZqdpvJTZcQOKnrE58YFmtipjeEXfKCyit0qWOM78_mnAZ504hFCudnRdlMMWKxnp5rQEXmlfh73xirR3Xcyvpv6CfGEporeBmt6gclph5zwx4JSvUj43aTVM85t3H1IVRssG3G6_7ze1OAu8219oEd_S3dfyFnOnFWFpoXl-hlnN2s8LQYrOXgOuV8a4znoOOP-rJq-gNS3CPn2RMe0U.l7IBC4HFcLPQmKexMIM_OJsAmwZ0bGiMPcsNA9ctAT0&dib_tag=se&keywords=nitrotech+ripped+protein&qid=1711647399&sr=8-8

and

https://www.amazon.co.uk/MuscleTech-NitroTech-Protein-Weightloss-Servings/dp/B0CW9Y3LB4/ref=sr_1_10?dib=eyJ2IjoiMSJ9.j2lnQLFdow5hZMjAS0VapCW7FprAvMaME9nY1JiRN4HvrT781gvZsEgS7M6k8dmtsO-TxY7Y589UwAM7D80WZnQZqdpvJTZcQOKnrE58YFmtipjeEXfKCyit0qWOM78_mnAZ504hFCudnRdlMMWKxnp5rQEXmlfh73xirR3Xcyvpv6CfGEporeBmt6gclph5zwx4JSvUj43aTVM85t3H1IVRssG3G6_7ze1OAu8219oEd_S3dfyFnOnFWFpoXl-htmH9UvsX5v_yggSDq5HVnlrEqoHkoMLXVZnm3Bf-fGI.QAePYc7xczEiBqffbdXuz7YDIQOSSlw0c8m3CjlDeZg&dib_tag=se&keywords=nitrotech+ripped+protein&qid=1711647780&sr=8-10

there may be other flavours but you get the gist at least on sale in europe

nowt so far re boots online - as far as i can decipher

mol

Https://www.nasdaq.com/press-release/verona-pharma-reports-fourth-quarter-and-full-year-2023-financial-results-and

sound familiar?

mol

True regarding reporting every quarter with a wealth of info not available /required under aim

However VRP went down that route ..........

and I know how that went and it wasn't a success (jees they even rang the opening bell to rapturous applause)

delisted from aim c 2020

however their ADS still on nasdaq under vrna

https://www.nasdaq.com/market-activity/stocks/vrna

mol

They have released their own press release dated 18th Mar but i believe actually released to public today 19th

Gurugram, India – March 18, 2024 – Dr. Morepen, a trusted brand from Morepen

Laboratories (NSE: MOREPEN) known for household staples like Burnol and Lemolate,

announced a partnership with OptiBiotix Health plc (AIM: OPTI) to introduce a transformative

weight management solution to the Indian market.

"At Dr. Morepen, we've consistently empowered individuals to lead healthier lives," said

Varun Suri, CEO – Consumer Care at Morepen. "This collaboration with OptiBiotix’s

SlimeBiome (sic) allows us to take a significant step forward in addressing the alarming rise of

obesity in India.”

https://www.morepen.com/public/uploads/media/Morepen65f982b98b079.pdf

transformative and significant - their words

mol

Not sure that you have converted indian rupees or lakh to sterling correctly aquae

their financial statements look pretty impressive to me

and didn't note slimbiome on link provided

but if you have found your assertion re spending a lot of money promoting - i'll take that all day long

mind i also thought you would be one of the first to study links provided

best wishes

mol

Sold out? jees did they not order enough?

or is this just a prelim page on their website in advance of launch

https://muscletech.co.uk/products/nitro-tech-ripped

mol

Plenty of info available for anyone interested

https://www.morepen.com/investors

https://economictimes.indiatimes.com/morepen-laboratories-ltd/stocksupdate/companyid-11215.cms

and latest results (to Dec 23 and available as from 31 Jan 24 ) albeit not audited and whilst they will have an accounting team behind same - they will also have an abundance of transactions to record above our scant number

no reason why we cannot do the same once myers beds in - i'm not holding my breath though ( and it was once muted re a listing on nasdaq - can't remember who discussed it on here at time lol - I said at time not going to happen and continue to hold said view )

https://www.morepen.com/public/uploads/investor/Morepen65bb97fa1e35f.pdf

mol

Https://www.youtube.com/watch?v=xqOMuR5Z530

mol

4 hours ago

Stick with it...

I am 6 months in, haven't missed a day and most importantly...haven't done anything else. 20 plus years of on and off psoriasis. Covid and family losses collided and from 2020 I'd been in a flare which saw, small patches grow and join until my body was around 80/90% covered. Badly, deep deep flare. I am now down to 50% and that 50% is not deep, nowhere near as cracked,layered and sore. It will all be gone for good by my 12 month AxisBiotix anniversary!!🎉

Date of experience: 12 March 2024

8 hours ago

Impressed!!

Stick with it! I really, really like this product but it does take time to kick in. I am now 3 months in and have just started to see a positive effect. I’ve suffered with psoriasis for about 10 years, predominantly scalp psoriasis and plaques across my stomach and back. I’ve tried lots of treatments under a dermatologist, from steroid creams to immunosuppressants drugs. Whilst effective, I found them quite harsh and not really long term solutions.

Since starting AxisBiotix, the plaques on my body have completely cleared and I am now able to manage my scalp psoriasis with a topical shampoo, rather than a daily steroidal ointment soak.

I am interested to see how the next 6 months go.

mol

Https://www.dailymail.co.uk/tvshowbiz/article-13186513/Jess-Wright-toned-figure-bikini-holiday-Dubai-son-husband.html

mol

Professor McBain at this conference in June

Presentation Outline

The potential role of the microbiome in overall skin health and in skin ageing is being increasingly recognised. Microbiome research is often complicated by considerations of correlation versus causation, and this applies to studies of human ageing as much as anywhere else. However, ageing-related changes in microbiome composition have been reported and ongoing research should focus on potential mechanisms, which may involve direct interaction with the skin and the host immune system, and the production of microbial metabolites. Microbiome-based interventions, such as probiotics, prebiotics, and postbiotics, have emerged as potential therapeutic strategies to modulate the skin microbiome and promote healthy skin ageing. This presentation will explore the current understanding of the skin microbiome's role in ageing and discuss potential microbiome-based interventions for promoting healthy skin ageing.

https://summit-events.com/anti-ageing/speaker-programme

mol

Cheers Aquae

mol

Or not perhaps

https://www.dermatonics.co.uk/collections/shop

heel balm, as anyone here, should know just one of a number of products making up the last reported turnover of £1.86m

which i found underwhelming given the price paid

and i'm also not overly impressed with umesh modi website - nor their turnover - at least what appears to be their reported turnover - as one who has tried over a number of years to gain an insight into privately owned companies in India - not an easy exercise and also, whilst an extemely large potential market, not one that readily avails itself to outside companies.

but after all the back slapping and self promotion amongst a number of posters here

nobody has actually then put a figure on the increased turnover expected in say year ended 31 Jun 2025 - or am i wrong - but even more importantly profit before tax to bottom line from this

20 February 2024 - SkinBioTherapeutics plc, (AIM: SBTX, or the "Company"), the life science business focused on skin health, announces that its newly acquired company Dermatonics is set to launch Pheet and Dermatonics Once Heel Balm in Asia, Middle East and Africa (AMEA) in partnership with the Umesh Modi Group (the Group) following the signing of a manufacturing and distribution agreement on 30 June 2023.

Pheet and Dermatonics products are used for the treatment of dry foot skin and are sold under the Dermatonics brand in the rest of the world. The Once Heel Balm product will be manufactured by the Umesh Modi Group and sold directly by its sales team of over 1,200 people across six countries including India, Bangladesh Sri Lanka and Nigeria. The total addressable market in these regions for dermatology and diabetes management is in excess of £5bn. This collaboration is currently at an early stage, therefore, the management does not expect any changes to current market expectations at this stage.

mad after all

mol

Well even I didn't expect such a rise in my assistance - I'm obviously claiming the credit

jees not mad afterall

though perhaps even harder to expain why you are not mad when you are mad

mol

Https://soundcloud.com/optibiotix-investor/february-29th-2024

Something to listen to over the weekend

mol

Evening grizzlyb

just popped in this evening, after a number of years, and whilst not surprised at all re the suspension i sincerely hope you haven't lost any money here

i remember well our discussions of old

bw for the future

and anyone else still here after all these years

jees at one point exosomes were only the icing on the cake

mol

I've actually more than doubled my holding this afternoon

mind

I've been mad for ******* years, absolutely years

Been over the edge for yonks

Been working me buns off for bands

I've always been mad, I know I've been mad

Like the most of us, very hard to explain why you're mad

Even if you're not mad

mol

Our FD (albeit part-time) was only appointed on 4th Dec 2023

https://www.optibiotix-ir.com/content/news/archive/2023/041223

but now also noted on website

https://optibiotix.com/corporate/

albeit i accept an update to the revenue potential from May 2023 slides , prior to his appointment, would be more than useful - but give him a bit more time!

slides here - which at time of release i noted underwhelming for 2024 and even 2025

https://www.walbrookpr.com/docs/librariesprovider48/default-document-library/investors/optibiotix---investor-presentation-may-2023.pdf

just reminding the bb re the only figures we have to date - again as far as i'm aware

mol

Evening all

a positive step forward indeed and further improvement on the last rns only c 3 weeks ago

https://www.optibiotix-ir.com/content/news/archive/2024/300124

a reminder from May 2023 presentation and deals signed - albeit nothing since on dsm-firmenich % royalty, as far as i'm aware, unlike US partner

SweetBiotix: A portfolio of sweet low-calorie fibres created by combining prebiotic functional fibres and modified mogrosides or steviol glycosides in a single enzymatic step

Commercial Status:

i. Manufacturing agreement signed with US partner September 2020 for mogroside product

i. Scale up optimization completed/optimised products received December 2022 as liquid, freeze dried in May

ii. Partner taste testing confirms product acceptability. Analytical testing and structural analysis underway

iii. Structural analysis underway to determine novelty and the regulatory pathway

iv. Independent peer reviewed publication confirms sweetness and prebiotic functionality highlighting health benefits – start of marketing

v. Six figure annual milestone paid during scale up plus six figure launch milestone

vi. Royalties 5% plus a further 5% on 11 named companies( Kelloggs, Nestle, Coca Cola ,Firmenich, Tereos, Cargill, Arla ,Tate and Lyle, Agropur, Givaudan, Tata)

ii. Agreement signed with Firmenich July 2022 for stevia glycoside product

i. Manufacturing agreement signed and project progressing rapidly

ii. Manufacturing scale up underway, product produced and tested, process optimization underway to enhance yield

iii. Payments: Six figure payment per market approval (USA/Europe/Asia) - potential H2 2023/H1 2024

iv. One off six figure milestone when reaching $5m and $12m sales plus royalties on all sales

Next Steps:

Structural and functional analysis, regulatory approvals, partner application development and launch discussions

which more or less is noted in

https://www.optibiotix-ir.com/content/news/archive/2023/190723

mol